{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:21:06Z","timestamp":1790061666161,"version":"4.0.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/gme.0b013e3181ca0c74","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T09:34:37Z","timestamp":1268904877000},"page":"524-528","source":"Crossref","is-referenced-by-count":12,"title":["Estrogen therapy and risk of breast cancer in postmenopausal women"],"prefix":"10.1097","volume":"17","author":[{"given":"Franco","family":"Lumachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Chiara","family":"Frigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tombolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210227","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1586\/14737140.2.2.169","article-title":"Combination chemotherapy for metastatic breast cancer.","volume":"2","author":"Nabholtz","year":"2002","journal-title":"Expert Rev Anticancer Ther"},{"key":"R3-15-20210227","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/jnci\/89.18.1373","article-title":"Geographic variation in breast cancer incidence rates in a cohort of U.S. women.","volume":"9","author":"Laden","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"R4-15-20210227","first-page":"3565","article-title":"Breast cancer risk in symptomatic women spontaneously undergoing clinical breast examination.","volume":"23","author":"Lumachi","year":"2003","journal-title":"Anticancer Res"},{"key":"R5-15-20210227","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-072X-3-17","article-title":"The geographic distribution of breast cancer incidence in Massachusetts 1988 to 1997, adjusted for covariates.","volume":"3","author":"Sheehan","year":"2004","journal-title":"Int J Health Geogr"},{"key":"R6-15-20210227","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study.","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"R7-15-20210227","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jnci\/86.7.505","article-title":"Breast cancer among young U.S. women in relation to oral contraceptive use.","volume":"86","author":"White","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R8-15-20210227","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ijc.11307","article-title":"Oral contraceptive use and risk of breast cancer by histologic type.","volume":"106","author":"Newcomer","year":"2003","journal-title":"Int J Cancer"},{"key":"R9-15-20210227","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4065\/81.10.1290","article-title":"Oral contraceptives use as a risk factor for premenopausal breast cancer: a meta-analysis.","volume":"81","author":"Kahlenborn","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R10-15-20210227","first-page":"145","article-title":"Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy.","volume":"5","author":"Brinton","year":"1998","journal-title":"Menopause"},{"key":"R11-15-20210227","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.22699","article-title":"Hormone replacement therapy and breast cancer in former users of oral contraceptives-The Norwegian Women and Cancer Study.","volume":"121","author":"Lund","year":"2007","journal-title":"Int J Cancer"},{"key":"R12-15-20210227","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10552-004-8024-z","article-title":"Previous contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.","volume":"16","author":"Dumeaux","year":"2005","journal-title":"Cancer Causes Control"},{"key":"R14-15-20210227","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.","volume":"283","author":"Schairer","year":"2000","journal-title":"JAMA"},{"key":"R15-15-20210227","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0753-3322(02)00252-4","article-title":"Breast cancer risk in healthy and symptomatic women: results of a multivariate analysis. A case-control study.","volume":"56","author":"Lumachi","year":"2002","journal-title":"Biomed Pharmacother"},{"key":"R16-15-20210227","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1016330024268","article-title":"Estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada.","volume":"13","author":"Kirsh","year":"2002","journal-title":"Cancer Causes Control"},{"key":"R17-15-20210227","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","article-title":"Cancer statistics.","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"R18-15-20210227","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","article-title":"The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.","volume":"332","author":"Colditz","year":"1995","journal-title":"N Engl J Med"},{"key":"R19-15-20210227","first-page":"1046","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer.","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"R20-15-20210227","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10147-007-0728-0","article-title":"No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan.","volume":"13","author":"Saeki","year":"2008","journal-title":"Intern J Clin Oncol"},{"key":"R21-15-20210227","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jama.281.16.1528","article-title":"Hormone replacement therapy and high S phase in breast cancer.","volume":"281","author":"Cobleigh","year":"1999","journal-title":"JAMA"},{"key":"R22-15-20210227","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.bjc.6690543","article-title":"Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients.","volume":"80","author":"Jernstrom","year":"1999","journal-title":"Br J Cancer"},{"key":"R23-15-20210227","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1006315607241","article-title":"The effect of estrogen usage on the subsequent hormone receptors status of primary breast cancer.","volume":"58","author":"Lower","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"R24-15-20210227","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/cncr.20499","article-title":"Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.","volume":"101","author":"Chen","year":"2004","journal-title":"Cancer"},{"key":"R25-15-20210227","first-page":"491","article-title":"Relationship between oral contraceptive therapy and estrogen receptor status in patients with breast cancer.","volume":"28","author":"Lumachi","year":"2008","journal-title":"Anticancer Res"},{"key":"R26-15-20210227","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/bcr2145","article-title":"Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.","volume":"10","author":"Rosemberg","year":"2008","journal-title":"Breast Cancer Res"},{"key":"R27-15-20210227","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1783\/147118903101198042","article-title":"Progestogens and breast cancer risk: the role of hormonal contraceptives and hormone replacement therapy.","volume":"29","author":"Marsden","year":"2003","journal-title":"J Fam Plann Reprod Health Care"},{"key":"R28-15-20210227","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1001\/jama.289.24.3254","article-title":"Relationship between long duration and different regimens of hormone therapy and risk of breast cancer.","volume":"289","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"R29-15-20210227","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/ERC-06-0060","article-title":"Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.","volume":"14","author":"Biglia","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"R30-15-20210227","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1471-0528.2007.01520.x","article-title":"Hormone replacement therapy use and variations in the risk of breast cancer.","volume":"115","author":"Opatrny","year":"2008","journal-title":"Br J Obstet Gynaecol"},{"key":"R31-15-20210227","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jnci\/djm059","article-title":"Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.","volume":"99","author":"Glass","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R32-15-20210227","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5694\/j.1326-5377.2008.tb01821.x","article-title":"Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia.","volume":"188","author":"Canfell","year":"2008","journal-title":"Med J Aust"},{"key":"R33-15-20210227","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ijc.23163","article-title":"The association between oral contraceptive use and lobular and ductal breast cancer in young women.","volume":"122","author":"Nyante","year":"2008","journal-title":"Int J Cancer"},{"key":"R34-15-20210227","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4065\/81.10.1290","article-title":"Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis.","volume":"81","author":"Kahlenborn","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R35-15-20210227","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies.","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"R36-15-20210227","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e31818e8cd6","article-title":"Breast cancer risk in postmenopausal women using estradiol-progesterone therapy.","volume":"113","author":"Lyytinen","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R37-15-20210227","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.22001","article-title":"Breast cancer risk in relation to abortion: results from the EPIC study.","volume":"119","author":"Reeves","year":"2006","journal-title":"Int J Cancer"},{"key":"R38-15-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/gme.0b013e3181ca0c74","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:34:44Z","timestamp":1620977684000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201017030-00015"}},"subtitle":["a case-control study and results of a multivariate analysis"],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181ca0c74","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}